Neocis, Inc. recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for a new Yomi edentulous indication.
With the clearance, the dental robotic system can assist with full arch implant treatment by using a new splint attachment, according to a press release. This broadens its applications to include full arch implant cases as well as partially edentulous cases, allowing clinicians to treat more patients and restore more smiles.
Yomi’s minimally invasive full arch protocol reduces time to surgery while improving surgical efficiency and accuracy. The splints are stable, easy to use and accurate. The system also provides optimal visibility in the surgical field.
View Full Press Release